Drug-eluting stent

Global Bioabsorbable Stents Market Forecast 2020-2025 Featuring Key Players - Abbot Laboratories, Elixir Medical, Reva Medical, Kyoto Medical Planning - ResearchAndMarkets.com

Tuesday, October 20, 2020 - 9:28am

To overcome these roadblocks biodegradable stents came into existence in the recent years and is expected to considerably replace traditional stents.

Key Points: 
  • To overcome these roadblocks biodegradable stents came into existence in the recent years and is expected to considerably replace traditional stents.
  • The bioabsorbable stents market is classified on the basis of material used for manufacturing the products including polymeric and metallic.
  • Metal bioabsorbable stents are luring the medical device providers as they have the potential to perform similarly to stainless steel metal stents.
  • The key players in bioabsorbable stents market include:

OPTIMIZE Study Reports Lowest TLR Ever Achieved in an Investigational Device Exemption (IDE) Study With Svelte Medical System’s Bioresorbable Coated Drug-Eluting Coronary Stent

Saturday, October 17, 2020 - 5:00pm

The Svelte Drug-Eluting Stent (DES) achieved 1.5% clinically-driven Target Lesion Revascularization (TLR) at 1 year, the lowest ever reported in an Investigational Device Exemption (IDE) clinical study.

Key Points: 
  • The Svelte Drug-Eluting Stent (DES) achieved 1.5% clinically-driven Target Lesion Revascularization (TLR) at 1 year, the lowest ever reported in an Investigational Device Exemption (IDE) clinical study.
  • The high TLF reported in both OPTIMIZE treatment groups is driven by the 25% of study subjects assessed peri-procedurally with high-sensitivity-troponin.
  • We are deeply grateful to each and every one of the patients, investigative team members and support personnel contributing to the OPTIMIZE study.
  • Headquartered in New Providence, New Jersey, Svelte Medical Systems ( www.sveltemedical.com ) is a privately-held company engaged in the development of highly deliverable balloon expandable stents.

Global Peripheral Stents Market Insights to 2024 - Players Include Abbott, Biotronik and Boston Medical Among Others - ResearchAndMarkets.com

Friday, October 16, 2020 - 3:26pm

The "Global Peripheral Stents Market" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Peripheral Stents Market" report has been added to ResearchAndMarkets.com's offering.
  • This report was developed using extensive primary and secondary research by the publisher's analysts.
  • Data from proprietary databases, proprietary market reports, company reports, import/export databases, and secondary data sources on medical device markets were used to develop estimates of 2019 worldwide market size by product segment, ASPs, sales, and market share for the top suppliers by product segment.
  • Devices in this global market analysis include peripheral vascular stents, iliac artery stents, biliary stents, tracheobronchial stents.

Global Interventional Cardiology Devices Market (2020 to 2025) - Growth, Trends, and Forecasts - ResearchAndMarkets.com

Thursday, October 15, 2020 - 11:44am

The United States, currently, is expected to continue with its largest share in the coronary stents market.

Key Points: 
  • The United States, currently, is expected to continue with its largest share in the coronary stents market.
  • Much of the demand for and production of interventional cardiology devices are taken up by North America and Europe.
  • North America has a high consumption rate of premium-priced interventional cardiology devices, and it is the region that can cater to a high rate of innovation in medical devices, thus, dominating this market.
  • However, problems related to varying rates of degradation and uneven drug release have delayed the introduction of the bioabsorbable stents in the market.

Large Study Demonstrates Exceptional Safety and High Procedural Success With Cardiovascular Systems’ Diamondback 360® Coronary Orbital Atherectomy System (OAS)

Wednesday, October 14, 2020 - 1:00pm

The Diamondback 360 Coronary OAS uses a powerful dual mechanism of action to treat both superficial and deep calcium.

Key Points: 
  • The Diamondback 360 Coronary OAS uses a powerful dual mechanism of action to treat both superficial and deep calcium.
  • Scott Ward, Chairman, President and Chief Executive Officer, said, This study expands our evidence demonstrating the safe, effective use of orbital atherectomy to treat a real-world complex patient population.
  • 1 Orbital Atherectomy System for Treating De Novo, Severely Calcified Coronary Lesions: A Tertiary Center Experience.
  • Indications: The Diamondback 360 Coronary Orbital Atherectomy System (OAS) is a percutaneous orbital atherectomy system indicated to facilitate stent delivery in patients with coronary artery disease (CAD) who are acceptable candidates for PTCA or stenting due to de novo, severely calcified coronary artery lesions.

Coronary Stents Pipeline Insight and Competitive Landscape Report 2020: Insights on 20+ Companies and Pipeline Devices - ResearchAndMarkets.com

Friday, October 9, 2020 - 12:48pm

The "Coronary Stents Pipeline Insight and Competitive Landscape, 2020" drug pipelines has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Coronary Stents Pipeline Insight and Competitive Landscape, 2020" drug pipelines has been added to ResearchAndMarkets.com's offering.
  • The Coronary Stents - Pipeline Insight and Competitive Landscape, 2020, report provides comprehensive insights about 20+ companies and 20+ pipeline devices in Coronary Stents pipeline landscape.
  • Owing to the rise in the prevalence of coronary artery diseases (CAD), the coronary stents market is witnessing remarkable growth.
  • This reports provides a detailed study of the emerging coronary stents devices along with competitive landscape to help better understand the market.

Global Drug Device Combination Products Market Trajectory & Analytics, 2020-2027: Amid the COVID-19 Outbreak, the Market is Projected to Reach a Revised $133.3 Billion - ResearchAndMarkets.com

Friday, September 25, 2020 - 12:51pm

The "Drug Device Combination Products - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Drug Device Combination Products - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • Amid the COVID-19 crisis, the global market for Drug Device Combination Products estimated at US$90.3 Billion in the year 2020, is projected to reach a revised size of US$133.3 Billion by 2027, growing at a CAGR of 5.7% over the analysis period 2020-2027.
  • Drug Eluting Stents, one of the segments analyzed in the report, is projected to record a 5.1% CAGR and reach US$14 Billion by the end of the analysis period.
  • The U. S. Market is Estimated at $24.4 Billion, While China is Forecast to Grow at 8.8% CAGR
    The Drug Device Combination Products market in the U. S. is estimated at US$24.4 Billion in the year 2020.

Global Coronary Stents Market to Surpass US$ 15,109.2 Million by 2027, Says Coherent Market Insights (CMI)

Monday, September 14, 2020 - 3:05pm

According to Coherent Market Insights, the global coronary stents market is estimated to be valued at US$ 8,985.6 million in 2020 and is expected to exhibit a CAGR of 7.7% during the forecast period (2020-2027).

Key Points: 
  • According to Coherent Market Insights, the global coronary stents market is estimated to be valued at US$ 8,985.6 million in 2020 and is expected to exhibit a CAGR of 7.7% during the forecast period (2020-2027).
  • Key Trends and Analysis of the Global Coronary Stents Market:
    Key trends in the market are the increasing incidence of cardiovascular diseases, strategic collaborations and acquisitions among key players, and product launches.
  • Furthermore, key players operating in the global coronary stents market are focusing on launch of novel coronary stents which is expected to drive the market growth during the forecast period.
  • The global coronary stents market is expected to exhibit a CAGR of 7.7% during the forecast period owing to an increasing number of product approvals.

2020 Market Study on the Future of Therapy: Technology Advances in Drug-device Combination Products - ResearchAndMarkets.com

Monday, August 10, 2020 - 2:49pm

3.2.6 Moderate to Low Patent Activity of Drug-eluting Contact Lens with Johnson & Johnson Vision Care Inc., Showing High Activity

Key Points: 
  • 3.2.6 Moderate to Low Patent Activity of Drug-eluting Contact Lens with Johnson & Johnson Vision Care Inc., Showing High Activity
    4.2 Future of Coronary Stents: Gene Eluting Stents to Overcome Restenosis and Late-stent Thrombosis Challenges
    4.6 Business Growth Opportunities - Patient Centric, Patient Specific, and Cost-effective Imaging Redefining Future of Therapy
    View source version on businesswire.com: https://www.businesswire.com/news/home/20200810005426/en/

Urinary Tract Stents (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact)

Monday, August 3, 2020 - 5:50pm

Urinary Tract Stents (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within General Surgery therapeutic area.

Key Points: 
  • Urinary Tract Stents (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within General Surgery therapeutic area.
  • - Annualized total Urinary Tract Stents market revenue by segment and market outlooks from 2015-2030.
  • - Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Urinary Tract Stents market in the future.
  • - Track device sales in the global and country-specific Urinary Tract Stents market from 2015-2030.